Immix Biopharma, Inc. (NASDAQ:IMMX) IPO
IPO
Priced at US$5.00 a share on Dec 15, 2021.
- Price
- US$5.00 a share
- Shares offered
- 4,200,000 shares of common stock
- Offering size
- US$21 million
- Underwriters' option
- Up to 630,000 more shares
- Listing
- IMMX on the Nasdaq Capital Market
- Underwriter
- ThinkEquity
- Shares delivered
- On or about Dec 20, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 20, 2021 |
| Filed publicly | Sep 17, 2021 |
| Amended 4 times | Newest Nov 4, 2021 |
| Shares registered with an exchange | Dec 13, 2021 |
| Declared effective by the SEC | Dec 15, 2021 |
| Final prospectus, with the price | Dec 17, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Dec 17, 2021 |
| EFFECT · Notice that a registration is effective | Dec 15, 2021 |
| CERT · Exchange's certificate of listing | Dec 14, 2021 |
| CORRESP · Letter to the SEC | Dec 13, 2021 |
| CORRESP · Letter to the SEC | Dec 13, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Dec 13, 2021 |
| FWP · Free writing prospectus | Dec 1, 2021 |
| S-1/A · Registration statement, amended | Nov 4, 2021 |
| S-1/A · Registration statement, amended | Oct 28, 2021 |
| S-1/A · Registration statement, amended | Oct 15, 2021 |
| CORRESP · Letter to the SEC | Oct 15, 2021 |
| UPLOAD · Letter from the SEC | Oct 13, 2021 |
| CORRESP · Letter to the SEC | Oct 6, 2021 |
| S-1/A · Registration statement, amended | Oct 6, 2021 |
| UPLOAD · Letter from the SEC | Sep 27, 2021 |
| S-1 · Registration statement | Sep 17, 2021 |
| CORRESP · Letter to the SEC | Sep 16, 2021 |
| UPLOAD · Letter from the SEC | Aug 16, 2021 |
| DRSLTR · Letter to the SEC with a draft | Jul 20, 2021 |
| DRS · Draft registration statement | Jul 20, 2021 |
From the cover of the final prospectus (424B4) filed Dec 17, 2021